Regulatory Webinars

  1. When Biological Sample Issues Become Regulatory Review Problems 7/17/2026

    In this video, Dr. Graham explains what led him to look more closely at clinical trial execution and what he uncovered when he mapped the path from sample collection to regulatory submission.

  2. From Chaos To Clarity: A Founder's View From 30 Years In Drug Development 7/16/2026

    Same workflows, higher stakes. A 30-year drug development veteran reveals how outdated sample handling puts trial outcomes at risk and what sponsors can do about it.

  3. The Power of AI To Advance Digital Health Innovation 6/18/2026

    Discover how leaders from Pfizer, Mayo Clinic, and the FDA use AI to advance digital endpoints in this 4-video recap of ADDS 2026. Learn to turn AI insights into scalable, regulatory-ready solutions.

  4. Barcode-Driven Verification: Enhancing Compliance 6/10/2026

    Investigational products present a distinctly high-risk environment for labeling and barcoding. Explore best practices for barcoding solutions that allow for improved medication safety in clinical trials.

  5. Strengthen Safety Data Flow For Your Outsourced Clinical Trial 6/3/2026

    Outsourced clinical trials risk safety missteps when communication falters. Learn how a clear, detailed data-flow process affects your safety decisions.

  6. AI Meets Informed Consent: Opportunity, Risk, And What IRBs Need To See 5/14/2026

    Expert perspectives on IRB oversight, health literacy, and research ethics offer practical guidance to strengthen consent, protect participants, and align compliance with real-world research.

  7. How To Best Navigate The Global Clinical Trial Registry Ecosystem 5/12/2026

    This presentation is your GPS, guiding you on a path that includes harmonization initiatives intended to improve transparency and data consistency across registries.

  8. Human Abuse Potential: Selecting A Positive Control 5/8/2026

    Choosing an effective positive control in HAP studies is critical but not always straightforward. Learn how to justify comparator and dose selection.

  9. Human Abuse Potential: CSS Interactions 5/8/2026

    Learn how, by embedding FDA engagement into the development process, sponsors can strengthen their abuse potential assessment and support smoother regulatory review.

  10. Pharmacy Considerations For Early Phase Trials 5/8/2026

    This presentation explores practical pharmacy considerations in early-phase clinical trials, offering real-world insights from experienced clinical research pharmacists.